ChiCTR2600123247 版本V1.0 版本创建时间2026/04/23 09:48:42 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600123247 

最近更新日期:

Date of Last Refreshed on:

2026-04-23 09:47:54 

注册时间:

Date of Registration:

2026-04-23 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

中老年抑郁症伴精神病性症状的多轴标志物机器学习识别模型研究

Public title:

A Study on Machine Learning-Based Identification Model for Multi-Axis Biomarkers of Depression with Psychotic Symptoms in Middle-Aged and Older Adults

注册题目简写:

English Acronym:

研究课题的正式科学名称:

中老年抑郁症伴精神病性症状的多轴标志物机器学习识别模型研究

Scientific title:

A Study on Machine Learning-Based Identification Model for Multi-Axis Biomarkers of Depression with Psychotic Symptoms in Middle-Aged and Older Adults

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

邵岩 

研究负责人:

邵岩 

Applicant:

Yan Shao 

Study leader:

Yan Shao 

申请注册联系人电话:

Applicant telephone:

+86 188 1133 2326

研究负责人电话:

Study leader's
telephone:

+86 188 1133 2326

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

xiangbei1991@bjmu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

xiangbei1991@bjmu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市海淀区花园北路51号

研究负责人通讯地址:

北京市海淀区花园北路51号

Applicant address:

51 Huayuan Bei Road, Haidian District, Beijing

Study leader's address:

51 Huayuan Bei Road, Haidian District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京大学第六医院

Applicant's institution:

Peking University Sixth Hospital

研究负责人所在单位:

北京大学第六医院

Affiliation of the Leader:

Peking University Sixth Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2026)伦审第(25)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京大学第六医院(精神卫生研究所)医学伦理委员会

Name of the ethic committee:

Ethics Committee of Peking University Sixth Hospital (Institute of Mental Health)

伦理委员会批准日期:

Date of approved by ethic committee:

2026-04-02 00:00:00

伦理委员会联系人:

王雪芹

Contact Name of the ethic committee:

Xueqin Wang

伦理委员会联系地址:

北京市海淀区花园北路51号

Contact Address of the ethic committee:

51 Huayuan Bei Road, Haidian District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10 6272 3770

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京大学第六医院

Primary sponsor:

Peking University Sixth Hospital

研究实施负责(组长)单位地址:

北京市海淀区花园北路51号

Primary sponsor's address:

51 Huayuan Bei Road, Haidian District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京市

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学第六医院

具体地址:

北京市海淀区花园北路51号

Institution
hospital:

Peking University Sixth Hospital

Address:

51 Huayuan Bei Road, Haidian District, Beijing

经费或物资来源:

北京大学第六医院培育基金

Source(s) of funding:

Peking University Sixth Hospital Foundation Fund

研究疾病:

抑郁障碍  

Target disease:

Depressive disorder

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

本研究旨在通过回顾性分析过去 12 年间 45 岁及以上住院患者的临床数据,比较伴与不伴精神病性症状的重度抑郁发作患者在 PSG 参数、炎症标志物、代谢指标、甲状腺功能及性激素水平上的差异,探索可用于辅助鉴别诊断的客观生物学指标。  

Objectives of Study:

This study aims to retrospectively analyze clinical data from inpatients aged 45 years and older over the past 12 years, compare differences in PSG parameters, inflammatory markers, metabolic indicators, thyroid function, and sex hormone levels between patients with major depressive episode with psychotic symptoms and those without, and explore objective biological indicators that can be used to assist in differential diagnosis.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 年龄≥45 周岁,性别不限; 2. 2014 年 1 月 1 日至 2025 年 12 月 31 日期间在北京大学第六医院老年科或睡眠科住院治疗; 3. 符合 ICD-10 重度抑郁发作诊断标准,具体编码包括: (1)F32.2 不伴有精神病性症状的重度抑郁发作 (2)F32.3 伴有精神病性症状的重度抑郁发作 (3)F33.2 复发性抑郁障碍,目前为不伴有精神病性症状的重度发作 (4)F33.3 复发性抑郁障碍,目前为伴有精神病性症状的重度发作; 4. 具有完整的住院病历记录,能够提取研究所需的核心变量信息。

Inclusion criteria

1. Age >= 45 years, with no gender restriction; 2. Inpatients admitted to the Department of Geriatric Psychiatry or the Department of Sleep Medicine, Peking University Sixth Hospital, between January 1, 2014 and December 31, 2025; 3. Meeting the ICD?10 diagnostic criteria for major depressive episode, with specific codes including: (1) F32.2 Major depressive episode, single episode, without psychotic symptoms; (2) F32.3 Major depressive episode, single episode, with psychotic symptoms; (3) F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms; (4) F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms; 4. Having complete inpatient medical records that allow extraction of core variable information required for the study.

排除标准:

1. 睡眠障碍:中-重度睡眠呼吸暂停(AHI≥15 次/min)、快动眼睡眠行为障碍; 2. 精神障碍:精神分裂症谱系障碍、双相情感障碍、恶劣心境; 3. 神经系统疾病:痴呆、帕金森病/综合征、癫痫、迟发性运动障碍; 4. 系统性疾病:干燥综合征、类风湿关节炎、系统性红斑狼疮、慢性肝炎、肝硬化、肾病综合征、支气管哮喘、慢性萎缩性胃炎、恶性肿瘤; 5. 内分泌疾病:任何临床甲状腺功能减退症(包括原发性、手术后)/亢进; 6. 急性事件:近 1 个月内感染(发热、感冒、肺炎等)、近 6 个月内急性心脑血管事件(急性脑梗死、不稳定性心绞痛、心肌梗死)、近 6 个月内重大手术; 7. 数据不完整:关键变量(分组变量或主要结局指标)缺失且无法通过原始病历补充者。

Exclusion criteria:

1. Sleep disorders:Moderate-to-severe sleep apnea (AHI >= 15 times/min), rapid eye movement sleep behavior disorder; 2. Psychiatric disorders:Schizophrenia spectrum disorders, bipolar disorder, dysthymia; 3. Neurological diseases:Dementia, Parkinson’s disease/syndrome, epilepsy, tardive dyskinesia; 4. Systemic diseases:Sj?gren’s syndrome, rheumatoid arthritis, systemic lupus erythematosus, chronic hepatitis, liver cirrhosis, nephrotic syndrome, bronchial asthma, chronic atrophic gastritis, malignant neoplasms; 5. Endocrine diseases:Any clinical hypothyroidism (including primary and postsurgical) or hyperthyroidism; 6. Acute events:Infections within the past 1 month (fever, cold, pneumonia, etc.), acute cardiovascular and cerebrovascular events within the past 6 months (acute cerebral infarction, unstable angina pectoris, myocardial infarction), major surgery within the past 6 months; 7. Incomplete data:Patients with missing key variables (grouping variables or primary outcome measures) that cannot be supplemented from the original medical records.

研究实施时间:

Study execute time:

From 2026-05-01 00:00:00 To 2027-05-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-05-01 00:00:00 To 2027-05-01 00:00:00

干预措施:

Interventions:

组别:

伴精神病性症状的抑郁障碍组

样本量:

150

Group:

Depressive disorder group with psychotic symptoms

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

不伴精神病性症状的抑郁障碍组

样本量:

350

Group:

Depressive disorder group without psychotic symptoms

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京市 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学第六医院 

单位级别:

三甲 

Institution
hospital:

Peking University Sixth Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

PSG 参数

指标类型:

主要指标

Outcome:

PSG parameters

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

炎症标志物

指标类型:

主要指标

Outcome:

Inflammatory markers

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

甲状腺功能

指标类型:

主要指标

Outcome:

Thyroid function

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

性激素水平

指标类型:

主要指标

Outcome:

Sex hormone levels

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 45 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

No

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用病历记录表收集数据,采用数据库管理数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data is collected by case record form and managed by database

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-04-23 09:47:54